PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL

Pharmacoepidemiological and pharmacoeconomical analysis of endometrit drug therapy at special treatment-and-prophylactic institutions of the city of Tomsk. Estimate the intensity of the appointment of antibacterial drugs endometrit therapy using the methodology of the WHO ATC/DDD, calculated indicat...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. Yu. Chernikova, M. V. Belousov
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2015-12-01
Series:	Бюллетень сибирской медицины
Subjects:	endometrit antibacterial therapy costs
Online Access:	https://bulletin.ssmu.ru/jour/article/view/383
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacoepidemiological aspects of antibacterial therapy of salpingoophoritis in hospital settings
by: E. A. Ushkalova, et al.
Published: (2018-03-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Pharmacoepidemiological and pharmacoeconomic analyses of the utilization of hypoglycaemic drugs in patients with type 2 diabetes mellitus in Moscow
by: Marina Fedorovna Kalashnikova, et al.
Published: (2015-06-01)

Pharmacoepidemiological Study of the Use of Antibacterial Agents in the Multi-Speciality Hospitals of St. Petersburg
by: S. V. Sidorenko, et al.
Published: (2020-05-01)

PHARMACOECONOMIC ASSESSMENT OF INTERMITTENT AND CONTINUOUS RENAL REPLACEMENT THERAPY
by: Yu. S. Polushin, et al.
Published: (2018-01-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2016-06-01)

Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer
by: Yu. Yu. Petukhova, et al.
Published: (2021-10-01)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015-03-01)

PHARMACOECONOMIC EFFECTIVENESS OF NAFTIDROFURYL IN PATIENTS WITH ISCHEMIC STROKE
by: A. N. Bogolepova, et al.
Published: (2017-07-01)

Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
by: O. S. Mikhaylova, et al.
Published: (2022-07-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS
by: E. E. Vidyakina, et al.
Published: (2016-09-01)

Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

VI CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»
Published: (2015-03-01)

VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»
Published: (2015-03-01)

VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»
Published: (2015-03-01)

Pharmacoeconomic aspects of the treatment of diabetic foot syndrome
by: Marina Fedorovna Kalashnikova, et al.
Published: (2010-06-01)

Pharmacoepidemiology of stroke treatment in different hospitals
by: N. V. Mikheeva, et al.
Published: (2015-03-01)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01)

Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
by: Eva Martínez-Moragón, et al.
Published: (2019-05-01)

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings
by: O. V. Zhukova, et al.
Published: (2019-10-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
by: A. A. Taube, et al.
Published: (2023-11-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
by: Ivan I. Dedov, et al.
Published: (2017-12-01)

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

Pharmacoeconomics of chronic kidney disease
by: R. I. Yagudina, et al.
Published: (2018-02-01)

PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM
by: A.S. Kolbin, et al.
Published: (2010-02-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
by: S. V. Nedogoda, et al.
Published: (2022-03-01)

Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer
by: O. P. Bobrova, et al.
Published: (2021-10-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

ANTIBACTERIAL THERAPY OF INFECTED PANCREATIC NECROSIS IN A MULTIFIELD SURGICAL HOSPITAL
by: V. V. Saveliev, et al.
Published: (2012-07-01)

Septic shock in the intensive care unit of a multidisciplinary hospital
by: L. L. Plotkin, et al.
Published: (2024-12-01)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
by: N. K. Mazina, et al.
Published: (2017-05-01)